Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00910845 · ClinicalTrials.gov registry record · Phase 3

Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

A Phase 3 study of Overactive Bladder, sponsored by Allergan.

Completed
Registry status
Phase 3
Development phase
557
Enrollment target
2
Study locations

NCT00910845 is a Phase 3 study of Overactive Bladder that has completed, run by Allergan. The registered enrollment target is 557 participants, above the 199-participant average among 45 other Overactive Bladder trials with a reported enrollment target (180% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00910845, a Phase 3 study of Overactive Bladder, has completed, sponsored by Allergan.

COMPLETED
Registry status
Phase 3
Development phase
557 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to assess the safety and effectiveness of botulinum toxin type A (onabotulinumtoxinA) in treating patients with idiopathic overactive bladder with urinary incontinence.

Conditions Studied

Overactive Bladder

Interventions

  • DRUG normal saline
  • BIOLOGICAL onabotulinumtoxinA

Study Locations (2)

California

  • - Newport Beach

British Columbia

  • - Victoria

Trial Details

FieldValue
Enrollment Target 557 participants
Start Date 2009-09
Est. Completion 2011-07
Phase Phase 3

Sponsor

Allergan

314 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00910845

The ClinicalTrials.gov registry entry for NCT00910845 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 557 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 199-participant average among 45 other Overactive Bladder trials with a reported enrollment target (180% higher). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which normal saline is the first listed.

NCT00910845 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, British Columbia.

Frequently Asked Questions

What is clinical trial NCT00910845 about?

NCT00910845 is a clinical study titled "Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence". The purpose of this study is to assess the safety and effectiveness of botulinum toxin type A (onabotulinumtoxinA) in treating patients with idiopathic overactive bladder with urinary incontinence.

What is the current status of trial NCT00910845?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 557 participants. The study started on 2009-09. Estimated completion is 2011-07.

What conditions does trial NCT00910845 study?

This clinical trial studies the following conditions: Overactive Bladder.

What interventions are being tested in trial NCT00910845?

The interventions under investigation include: normal saline (DRUG), onabotulinumtoxinA (BIOLOGICAL).

Who is sponsoring clinical trial NCT00910845?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00910845 being conducted?

This trial has 2 study locations across California, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overactive Bladder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.